are they discontinuing tirzepatide being discontinued FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies required to cease When to Stop Tirzepatide: GLP-1

Plasma concentration is approximately 200 ng/mL at age 20, declining to roughly 80 ng/mL by age 60

A 48-year-old with a BMI of 38, prediabetes, sleep apnea, and a family history of early heart disease asks which drug to take

Alatassi's background includes a rigorous education and a passion for improving the health and well-being of her patients

SF-36v2 Acute Form Outcomes At 52 weeks, tirzepatide-pooled participants had statistically significant improved scores across all SF-36v2 domains (Fig

It works in a glucose-dependent manner, meaning its less likely to cause hypoglycemia on its own

Without proper metabolic support, progress can feel frustrating and slow